🚀 We’re excited to announce our partnership with Pearl Health to deliver the CMS Guiding an Improved Dementia Experience (#GUIDE) model to traditional Medicare beneficiaries aligned with Pearl’s provider partners. “Our mission is to ensure that individuals living with #dementia, along with their caregivers, receive the comprehensive and compassionate care they deserve," said Julius Bruch, MD PhD, CEO and Founder of Isaac Health. "Through this partnership, we aim to enhance the quality of life for our patients by providing accessible, person-centered support and alleviating the challenges faced by caregivers.” To learn more, read the full press release 👉 https://lnkd.in/e7QpXFWH #dementiacare #cmsguide #caregiversupport #alzheimers
Isaac Health
Hospitals and Health Care
New York, NY 1,290 followers
The best care for every brain
About us
Isaac Health is a virtual and in-home clinical service for dementia and other brain health conditions. Isaac Health partners with health systems and payers for screening, diagnosis, treatment, and ongoing care management at a population scale. Developed by leading neurological specialists, Isaac Health's proprietary care model is evidence-based and comprehensive, including services like medication management, cognitive rehabilitation, counseling, and psychosocial support. All of Isaac Health’s clinical services are in line with the gold standard of medical care, covered by insurance, and allow for fast access to specialists within days, not months. Isaac Health's mission is to radically improve access and brain health care outcomes for the population. Its thoughtful workflows and technology are built specifically for those at risk for and affected by Alzheimer’s disease and related neurological disorders — all to help patients and their families be as healthy and happy as possible, for as long as possible.
- Website
-
https://www.myisaachealth.com
External link for Isaac Health
- Industry
- Hospitals and Health Care
- Company size
- 11-50 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2022
- Specialties
- Alzheimer's, Vascular Dementia, Dementia, Lewy Body Dementia, Parkinson's Disease, Mild Cognitive Impairment, Brain Health, Cognitive Resilience, Cognitive Aging, Healthy Aging, Neurology, Behavioral Neurology, Cognitive Neurology, Neuropsychology, Cognitive Therapy, Cognitive Rehabilitation Therapy, Cognitive Remediation Therapy, Memory Care, Memory Disorders, Neurodegenerative Diseases, and Population Health
Locations
-
Primary
Get directions
New York, NY 10018, US
Employees at Isaac Health
-
Melissa Rowley
Advisor, Isaac Health, previous board chair and member of the Caregiver Action Network
-
Jessica Muse
Scaling Companies | Operator, Advisor, Investor | Tech-Enabled Services, Healthcare, Digital
-
Joel Salinas, MD, MBA, MSc, FAAN
Founder/CMO, Isaac Health; Neurologist, NYU School of Medicine & NYU Langone; former Harvard Med & MGH | Author | Speaker
-
Richard Orlan
Provider of comprehensive healthcare services to persons at risk
Updates
-
🌱 Our team keeps growing! 🌱 We're thrilled to have Trevor Wright, Annie Rabe, Dr. Bhavan Shah, Kelcey Helms, Tabitha Hancock, and Amy Watson join our team this month. Each of our new team members impressed us with their dedication to delivering exceptional care to persons living with dementia as well as their caregivers. Welcome aboard – we're excited to have you with us on this journey to make accessible, high quality #dementia care a reality. 💙 Interested in receiving care with Isaac Health? Book a free consultation with us to learn more about how we can help 👉 https://lnkd.in/ep5Fp_t8 We're hiring for more roles, including psychotherapists, geriatricians, neurologists, and care navigators! Check out our job postings here 👉 https://lnkd.in/eDgZ9pha #newhires #brainhealth #dementiacare
-
-
✨ Happening next week! ✨ Join us to learn about how the new CMS GUIDE Model can help your organization reduce #LTSS spend and improve health outcomes. Register now 👉 https://lnkd.in/eBC65a7q
The CMS GUIDE Model launched this week. What does this mean for managed care organizations? In our upcoming webinar on July 19 at 12pm ET, Isaac Health's founders Joel Salinas, MD, MBA, MSc, FAAN and Julius Bruch, MD PhD will discuss how GUIDE is set to transform advanced dementia care management for Medicaid and LTSS plans. During the session, they'll talk about: 👉 How advanced #dementia care management can delay and divert placement to LTC 👉 Access to around-the-clock support for members with dementia and family caregivers through Isaac Health's GUIDE Program 👉 The importance of closing cognitive and behavioral health diagnosis gaps Sign up for the webinar here: https://lnkd.in/eYvdxMqB #cmsguide #familycaregiver #ltss #medicaid #managedcare #mco
-
-
🎤 Our Chief Medical Officer Joel Salinas, MD, MBA, MSc, FAAN shared his thoughts on the FDA's recent approval of #donanemab on NeurologyLive. Tune in to learn more about what the new Alzheimer's drug means for patients and clinicians and how it's emblematic of a shift in neurology toward becoming more pathology-based.
Founder/CMO, Isaac Health; Neurologist, NYU School of Medicine & NYU Langone; former Harvard Med & MGH | Author | Speaker
Thank you Marco Meglio for having me on the NeurologyLive podcast last week! We had a great conversation about the FDA approval of #donanemab (brand name Kisunla) and what it means for patients, clinicians, and the field of neurology more broadly. Here's a synopsis of our discussion: Donanemab has the potential to have a strong positive impact on people living with dementia and their families. In addition to making more treatment options available to patients, the approval of donanemab can further dispel the myth that "nothing can be done" in the case of Alzheimer's disease, which negatively impacts patients' motivation to seek or access care for their symptoms in the first place. Furthermore, the approval of donanemab will motivate people to have conversations earlier – especially when faced with early signs of cognitive changes – which will be advantageous for early detection, early diagnosis, and thus early intervention. As for clinicians, I believe that it's important to be appropriately judicious. Determining which patients are a good fit for these treatments should include a thorough evaluation. Clinicians should also engage in the shared decision-making process with the patient and their loved ones when it comes to creating a person-focused treatment plan. These aren't easy decisions to make, and clinicians not only need to state the facts but also must translate the complexity of what we know (and what we don't know) into a language that patients can understand. Ultimately, it's important to help patients appreciate the benefits as well as the risks so that they can make the best decisions about their care. For the field as a whole, I believe that we're clearly at an inflection point: the treatment of ADRD will increasingly shift towards treatment and management using disease-modifying therapies. Over time, the treatment models will likely begin to parallel what we've seen in oncology and become more pathology based. As a behavioral neurologist, I hope that these exciting developments in neurology will encourage more people to specialize in this field and send a strong signal to pharmaceutical companies to continue investing in and developing new treatments for ADRD. Listen to the whole episode 👉 https://lnkd.in/e6hgN62m #alzheimers #adrd #kisunla
Special Episode: FDA Approves Donanemab for Early Symptomatic Alzheimer Disease
neurologylive.com
-
The CMS GUIDE Model launched this week. What does this mean for managed care organizations? In our upcoming webinar on July 19 at 12pm ET, Isaac Health's founders Joel Salinas, MD, MBA, MSc, FAAN and Julius Bruch, MD PhD will discuss how GUIDE is set to transform advanced dementia care management for Medicaid and LTSS plans. During the session, they'll talk about: 👉 How advanced #dementia care management can delay and divert placement to LTC 👉 Access to around-the-clock support for members with dementia and family caregivers through Isaac Health's GUIDE Program 👉 The importance of closing cognitive and behavioral health diagnosis gaps Sign up for the webinar here: https://lnkd.in/eYvdxMqB #cmsguide #familycaregiver #ltss #medicaid #managedcare #mco
-
-
Donanemab has received FDA approval ✔️ Branded as Kisunla™ (pronounced kih-SUHN-lah) by Eli Lilly and Company, donanemab is an amyloid plaque-targeting therapy for persons living with mild cognitive impairment (MCI) or in the mild dementia stage of Alzheimer’s disease with confirmed amyloid pathology. “This approval offers new hope to patients and families, as donanemab has shown promising results in slowing cognitive decline in early symptomatic stages of Alzheimer’s,” said Dr. Joel Salinas, MD, MBA, MSc, FAAN, Isaac Health’s Chief Medical Officer. “It is important to note that the treatment is specifically approved for those with confirmed Alzheimer’s pathology and mild cognitive impairment or mild dementia. This ensures that the therapy is targeted to those most likely to benefit.” Donanemab is the second Alzheimer’s drug of its kind to receive FDA approval, with the first such drug being lecanemab (brand name Leqembi – pronounced “leh-KEM-bee”), which was approved last year. Read more about it in our press release 👉 https://lnkd.in/eyuHZfUS #donanemab #kisunla #alzheimers #dementia
FDA Approval of Donanemab Marks Major Advance in Alzheimer's Treatment
https://www.myisaachealth.com
-
🧠 According to the 2024 Alzheimer's Association® report, dementia currently affects nearly 7 million Americans, with that number expected to double to 14 million by 2060. As healthcare costs for #dementia care are projected to soar to $1 trillion by 2050, unpaid #caregivers are already providing 18.4 billion hours of care annually. These caregivers face significant challenges: 70% are experiencing stress from coordinating care and 2/3 struggle to find necessary resources. Launching today, the CMS' GUIDE Model is designed to mitigate challenges faced by persons living with dementia and their families through comprehensive medical care, support, and resources. As an accepted participant in the GUIDE Model, Isaac Health is thrilled to offer advanced care management for persons living with dementia and their caregivers to address these critical issues, aiming to improve care coordination and health outcomes at a national scale. Key services provided by Isaac Health’s #GUIDE Program include: 🧑⚕️ Advanced community-based care management for dementia: Each GUIDE enrollee will have a dedicated care navigator and a neurology-led community team at Isaac Health, who will help them receive the right care and support. 🫰 Respite care covered by Medicare: Recognizing the need for caregivers to get support while they take care of other tasks, Isaac Health provides #respitecare with trained home care aides. 🫂 Caregiver training and support: Isaac Health’s GUIDE Program will provide essential caregiver training, support groups, and access to a 24/7 helpline to ensure everyone involved in care feels supported. Read the full press release 👉 https://lnkd.in/eSn3q_EF Learn more about how Isaac Health's GUIDE Model can support you and your loved ones 👉 https://lnkd.in/ej36PxgV
-
-
"For me, #dementia has always been very close to my heart. That started from growing up with my grandmother, [who] had an atypical form of dementia. Finding a diagnosis for her took a very long time, which meant that I experienced first-hand how hard it is to navigate [dementia] as a family." Our CEO Julius Bruch, MD PhD spoke with Dennis Kamara on the Decoding Health podcast about why he and co-founder Joel Salinas, MD, MBA, MSc, FAAN founded Isaac Health. In the podcast, Dr. Bruch talks about: 🧠 How Isaac Health is tackling disparities in dementia care through telehealth 🫂 Why the future of dementia care depends on #caregiver integration 💡 How payers are approaching Alzheimer's and dementia support Listen to the full podcast here 👉 https://lnkd.in/eV5Z4xim
-
-
Our webinar on GUIDE is happening today! 🚀 It's not too late to register 👉 https://lnkd.in/gyb7bRez
The Guiding an Improved Dementia Experience (GUIDE) model is the CMS’s new program for supporting Medicare beneficiaries living with #dementia, as well as their families. The program provides vital support and resources to eligible members in the form of personalized medical care, caregiver support, respite care, and a 24/7 support line. We're proud to share that Isaac Health will be a participant right from the launch in July 2024. In our upcoming webinar on June 26 at 12pm ET, Isaac Health's founders Joel Salinas, MD, MBA, MSc, FAAN and Julius Bruch, MD PhD will discuss what GUIDE means for healthcare providers, home health agencies, and health systems and how the innovative program can improve outcomes for patients living with dementia. The session will conclude with a Q&A, so come prepared with questions! Grab your spot today ➡️ https://lnkd.in/eZnMfpJG #webinar #guide #cms
-
-
✨ Happening this week! ✨ Join our webinar on Wednesday at 12pm ET to learn more about the GUIDE Model, CMS’s new program for supporting Medicare beneficiaries living with #dementia as well as their families. During the session and Q&A, Isaac Health's founders will discuss: 👉 What GUIDE means for healthcare providers and health systems 👉 Which services under GUIDE are covered by Medicare 👉 How Isaac Health's GUIDE program is unique Register now: https://lnkd.in/eZnMfpJG
-